Abbott Laboratories recently received FDA clearance for Tendyne, its transcatheter mitral valve replacement system. The news comes on the heels of Edwards Lifesciences Corp. securing a CE mark for its ...

Edwards Lifesciences is projected to deliver steady profit and revenue growth through 2026. Click here to read more on EW ...

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

For the first time in school history, Overton (31-8) is headed to the state baseball championships. The Mustangs prevailed ...

This was the stock's fourth consecutive day of gains.

A Relative Strength Rating upgrade for Edwards Lifesciences shows improving technical performance. Will it continue?

Despite the weak guidance, SentinelOne highlighted its improving profitability metrics. The company achieved a record free ...

St. Luke’s Heart and Vascular team became the first in the region to perform a transcatheter tricuspid valve replacement ...

Boston Scientific’s retreat from selling its ACURATE heart valves and halting FDA approval efforts created mild ripples in ...

Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement ...

Boston Scientific said it still expects to achieve its second-quarter and full-year 2025 sales and adjusted per-share earnings guidance despite the anticipated financial impacts from the ...